Alcon bought Aerie Pharmaceuticals Aerie Pharmaceuticals from 11/22/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Alcon completed its acquisition of Aerie Pharmaceuticals for $770 million, or 15.25 per share.

Aerie Pharmaceuticals

Review

Source:

{source} pictogram

investor.alcon.com

Vladimir Petenev

News editor

Write your comment first

News feed

Shareholders of Yandex approved dividends

9/11/24 YDEX

Bashkir chain TANTANA will use the Okolo franchise

9/11/24 X5

Aeroflot's passenger traffic in August grew by 13.4%

9/11/24 AFLT

X5 Retail Group is testing its own delivery using robots

9/11/24 X5

Magnit and Sambury launched Cenohit

9/11/24 MGNT

Promsvyazbank will enter the capital of CarMoney

9/11/24 CARM

Softline buys Test IT

9/11/24 SOFL

Henderson's August revenues were up 24.2%

9/10/24 HNFG

Artgen invests in biotech startup Aden

9/10/24 ABIO

Nornickel intends to create more than 100 new materials

9/10/24 GMKN